TP53 mutations in therapy-related acute myeloid leukemia: still the dark side of the moon?
Pol Arch Intern Med
.
2023 Jan 24;133(1):16416.
doi: 10.20452/pamw.16416.
Epub 2023 Jan 24.
Authors
Matteo Molica
1
,
Marco Rossi
2
Affiliations
1
Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy. molica@bce.uniroma1.it
2
Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
PMID:
36692041
DOI:
10.20452/pamw.16416
No abstract available
Publication types
Comment
MeSH terms
Humans
Leukemia, Myeloid, Acute* / genetics
Mutation
Tumor Suppressor Protein p53 / genetics
Substances
TP53 protein, human
Tumor Suppressor Protein p53